Adam Koppel
Director, 10% Owner · 1 filing · Latest: Apr 16, 2026
Kailera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
KLRA | Adam Koppel | Director, 10% Owner | Apr 20, 2026 | Purchase | $16.00 | 1,562,500 | $25.0M | 22,583,268 | |
KLRA | Adam Koppel | Director, 10% Owner | Apr 20, 2026 | Conversion | — | 21,020,768 | — | 21,020,768 | |